Alzheimer’s disease: experimental models and reality

By Eleanor Drummond, Thomas Wisniewski. Acta Neuropathologica, 2017

667 citations recorded by the source corpus.

Subfields: Cellular and Molecular Neuroscience, Computational Theory and Mathematics, Physiology

View Paper: https://www.semanticscholar.org/paper/14b0f96edcf55616021a5539c0bde2ef324c0a5c

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. Huaqiu Chen
2. Yun Zhang
3. Keenan Sterling
4. Weihong Song
5. Ran Li

Citations in the corpus

• Amyloid β-based therapy for Alzheimer’s disease: challenges, successes and future (2023, background): “In order to study Alzheimer’s pathogenesis and therapeutic strategies, better animal models to recapitulate the natural process of the disease are required.(443,444) Many transgenic mouse models have been developed and commonly used, including the mice containing mutations in the APP (e.”
• APP mouse models for Alzheimer's disease preclinical studies (2017, neutral): “Various AD mouse models (Onos et al , 2015; Puzzo et al , 2015; Drummond & Wisniewski, 2017) as well as other animal models including rats, non-human primates, Drosophila , and Caenorhabditis elegans (Drummond & Wisniewski, 2017) have been recently reviewed.”